Shares of M3, Inc. (OTCMKTS:MTHRF – Get Free Report) were up 11.1% on Monday . The company traded as high as $14.47 and last traded at $14.47. Approximately 50,200 shares changed hands during trading, an increase of 8,864% from the average daily volume of 560 shares. The stock had previously closed at $13.02.
Analyst Upgrades and Downgrades
Separately, The Goldman Sachs Group lowered M3 to a “neutral” rating in a research report on Thursday. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Hold”.
View Our Latest Research Report on M3
M3 Trading Up 11.1%
M3 Company Profile
M3, Inc provides medical-related services primarily to physicians and other healthcare professionals through Internet. The company operates through five reporting segments: Medical Platform, Evidence Solutions, Career Solutions, Site Solutions, and Overseas. It operates m3.com, a members-only web site for providing information to the healthcare professionals; MR-kun, where member doctors can independently and continuously receive information on the m3com platform; QOL-kun that provides life support information other than medical information to members; AskDoctors, where registered doctors answer questions about health and illness from the general public; MDLinx for medical professionals in the United States; and Doctors.net.uk, a website that provides developing services for pharmaceutical companies, as well as provides drug information database in France, Germany, and Spain.
Read More
- Five stocks we like better than M3
- Best Stocks Under $5.00
- FICO’s Big Dip Could Be the Best Buying Chance of the Year
- How to Use the MarketBeat Dividend Calculator
- D-Wave: Reevaluating the Short Seller’s Case After the Downgrade
- What is Insider Trading? What You Can Learn from Insider Trading
- Datavault: A Speculative AI Play, But Beware of Volatility
Receive News & Ratings for M3 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for M3 and related companies with MarketBeat.com's FREE daily email newsletter.